Cofilin is able to interact with the protein kinase ERK5 and both are recruited into the nucleus where they bind the transcription start site (TSS) of estrogen-stimulated genes upon hormone treatment of ERα-containing breast cancer cells. This evidence concerns the gene CFL1 and breast cancer.